Skip to main content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Prescription Drugs & Other Medical Products

Drugs and other medical products greatly impact human health and the health care system. ASPE conducts a variety of research in this area, including work related to medical product development and regulation; medical product markets, pricing and competition; prescription drug benefits and spending on medical products; medical product supply chains; and medical product safety.

Reports

Displaying 31 - 40 of 103. 10 per page. Page 4.

Advanced Search

Medication-Assisted Treatment for Opioid Use Disorder in the Child Welfare Context: Challenges and Opportunities

November 26, 2018
This brief describes four key challenges related to the use of medication-assisted treatment (MAT) in child welfare contexts for parents with opioid use disorder. It draws upon results from a mixed methods study examining how substance use affects child welfare systems across the country. Key challenges discussed include:
ASPE Issue Brief

Using Telehealth to Support Opioid Use Disorder Treatment Issue Brief

October 31, 2018
This Issue Brief was informed by an ASPE-funded study conducted by RTI International that assessed the use of telehealth to identify and manage SUDs in rural areas. The final research brief included an environmental scan and site visits with participants that represented a wide range of telehealth experiences throughout the country.

Comparison of U.S. and International Prices for Top Medicare Part B Drugs by Total Expenditures

October 24, 2018
The prices charged by drug manufacturers to wholesalers and distributors (commonly referred to as exmanufacturers prices) in the United States are 1.8 times higher than in other countries for the top drugs by total expenditures separately paid under Medicare Part B. U.S. prices were higher for most of the drugs included in the analysis, and U.S.

Addressing the Opioids Crisis: Data Sources and Linking Strategies

September 13, 2018
This report highlights key research questions and identifies opportunities to use existing data sources and implement data-linking strategies that can support the HHS five point strategy to combat the opioid crisis.
ASPE Data Point

Data point: Prescription Pharmaceutical Price Changes since the Release of the President’s Drug Pricing Blueprint

August 20, 2018
Using manufacturer-reported prescription pharmaceutical prices, we observe that the number of price increases has been reduced considerably since the release of the President’s Drug Pricing Blueprint, compared to the same time period in the year prior.

State and Local Policy Levers for Increasing Treatment and Recovery Capacity to Address the Opioid Epidemic: Final Report

August 6, 2018
This report summarizes financing and workforce policies that can be used by states to expand treatment access and capacity for opioid use disorder (OUD), focusing especially on medication-assisted treatment (MAT).
ASPE Data Point

Data Point: Savings Available Under Full Generic Substitution of Multiple Source Brand Drugs in Medicare Part D

July 22, 2018
ASPE analyzed Part D prescription drug event data from 2016 to estimate spending on brand drugs with generic therapeutic equivalents.

Economic Opportunity and the Opioid Crisis: Geographic and Economic Trends

June 28, 2018
This study examines relationships between indicators of economic opportunity and the prevalence of prescription opioids and substance use in the United States. We have three primary findings:

Substance Use, the Opioid Epidemic and the Child Welfare Caseloads: Methodological Details from a Mixed Methods Study

June 10, 2018
This brief describes the research methods used to produce the findings in Substance Use, the Opioid Epidemic, and Child Welfare Caseloads: A Mixed Methods Study. It is a part of a series of briefs that discuss different aspects and issues surrounding the relationship between substance use disorders and the child welfare system.

Substance Use, the Opioid Epidemic and the Child Welfare System: Key Findings from a Mixed Methods Study

March 6, 2018
This study examined the relationship between parental substance misuse and child welfare caseloads, which began rising in 2012 after more than a decade of decline.